CL2018001194A1 - Compuestos polimericos sol-gel y usos de los mismos - Google Patents
Compuestos polimericos sol-gel y usos de los mismosInfo
- Publication number
- CL2018001194A1 CL2018001194A1 CL2018001194A CL2018001194A CL2018001194A1 CL 2018001194 A1 CL2018001194 A1 CL 2018001194A1 CL 2018001194 A CL2018001194 A CL 2018001194A CL 2018001194 A CL2018001194 A CL 2018001194A CL 2018001194 A1 CL2018001194 A1 CL 2018001194A1
- Authority
- CL
- Chile
- Prior art keywords
- sol
- polymeric compounds
- gel polymeric
- gel
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250126P | 2015-11-03 | 2015-11-03 | |
| US201662315756P | 2016-03-31 | 2016-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018001194A1 true CL2018001194A1 (es) | 2019-05-17 |
Family
ID=57471981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018001194A CL2018001194A1 (es) | 2015-11-03 | 2018-05-03 | Compuestos polimericos sol-gel y usos de los mismos |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10064870B2 (es) |
| EP (1) | EP3370698B1 (es) |
| JP (1) | JP6864001B2 (es) |
| KR (1) | KR102145435B1 (es) |
| CN (1) | CN108601723B (es) |
| AU (1) | AU2016350868B2 (es) |
| BR (1) | BR112018009010B1 (es) |
| CA (1) | CA3002214C (es) |
| CL (1) | CL2018001194A1 (es) |
| ES (1) | ES2907686T3 (es) |
| MX (1) | MX2018005547A (es) |
| PL (1) | PL3370698T3 (es) |
| PT (1) | PT3370698T (es) |
| RU (1) | RU2761212C2 (es) |
| UY (1) | UY36973A (es) |
| WO (1) | WO2017079216A1 (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN109310705A (zh) * | 2016-03-18 | 2019-02-05 | 加拿大农业及农业食品部 | 干奶时加速乳腺退化和预防乳腺感染的方法 |
| MA44498A (fr) | 2016-03-31 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue |
| CR20180495A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Deribados de indol sustituidos como inhibidores de replicación viral del dengue |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| WO2017167952A1 (en) | 2016-04-01 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN110536679B (zh) | 2017-04-20 | 2023-03-31 | 硕腾服务有限责任公司 | 用于治疗乳腺炎的兽医用组合物和相关方法 |
| BR112019024195A2 (pt) | 2017-05-22 | 2020-06-23 | Janssen Pharmaceuticals, Inc. | Composto e composição farmacêutica de derivados de indolina substituídos como inibidores da replicação viral da dengue |
| EP3630724B1 (en) | 2017-05-22 | 2021-04-28 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| EP3634378A1 (en) * | 2017-06-09 | 2020-04-15 | Zoetis Broomhill IP Limited | Intramammary veterinary composition |
| CN109575484A (zh) * | 2017-09-29 | 2019-04-05 | 天津城建大学 | 新型埃洛石/聚乙烯醇复合气凝胶及其制备方法和应用 |
| JP2021504435A (ja) * | 2017-12-01 | 2021-02-15 | ゾエティス・サービシーズ・エルエルシー | ヒドロゲル組成物及びその使用 |
| US20190343875A1 (en) * | 2018-01-18 | 2019-11-14 | Zoetis Broomhill Ip Limited | Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow |
| CN113164009A (zh) * | 2018-11-22 | 2021-07-23 | 学校法人自治医科大学 | 内窥镜的视野确保用的粘弹性组合物 |
| WO2020118660A1 (en) * | 2018-12-14 | 2020-06-18 | Ecolab Usa Inc. | Stable iodine-containing antimicrobial teat dip compositions |
| CN110437471B (zh) * | 2019-07-11 | 2022-02-15 | 郑州轻工业学院 | 一种粘性复合水凝胶及其制备方法和用途 |
| CN115003626A (zh) * | 2019-12-20 | 2022-09-02 | 威利纳米有限公司 | 纳米结构二元凝胶组合物及其用途 |
| CN111012947B (zh) * | 2019-12-30 | 2021-11-12 | 南京财经大学 | 一种可注射和自愈合淀粉基水凝胶及其制备方法和应用 |
| CN111214699A (zh) * | 2020-01-08 | 2020-06-02 | 广州贝奥吉因生物科技股份有限公司 | 一种用于周围神经损伤修复的水凝胶及其制备方法 |
| CN111840212B (zh) * | 2020-06-18 | 2023-07-21 | 余祖功 | 一种非人类动物用乳头封闭剂及其制备方法 |
| CN111825858B (zh) * | 2020-07-02 | 2023-04-25 | 南京师范大学 | 一种基于两性离子和角蛋白的复合水凝胶及其制备方法 |
| WO2022217069A1 (en) * | 2021-04-09 | 2022-10-13 | Colorado School Of Mines | Radical crosslinked zwitterionic gels and uses thereof |
| EP4329790A1 (en) * | 2021-04-28 | 2024-03-06 | Mileutis Ltd. | Compositions and methods for modulating mammary disorders and conditions |
| CN113736435B (zh) * | 2021-10-08 | 2023-05-12 | 扬州工业职业技术学院 | 一种钻井液用纳米微乳液封堵剂及其制备方法 |
| CN114539574B (zh) * | 2022-02-28 | 2023-06-06 | 浙江农林大学 | 压电-摩擦电耦合感应材料的制备方法和应用 |
| CN115990275A (zh) * | 2022-10-08 | 2023-04-21 | 江苏省人民医院（南京医科大学第一附属医院） | 一种黏膜下注射剂及其制备方法 |
| CN115645635A (zh) * | 2022-10-24 | 2023-01-31 | 杭州旸顺医疗科技有限公司 | 一种液相栓塞剂及其制备方法和用途 |
| CN115804870B (zh) * | 2022-12-02 | 2023-12-19 | 浙江大学 | 一种微创注射生物支架及其制造方法与应用 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4333484A (en) | 1978-08-02 | 1982-06-08 | Philip Morris Incorporated | Modified cellulosic smoking material and method for its preparation |
| DE69629010T2 (de) | 1995-01-16 | 2004-04-15 | Baxter International Inc., Deerfield | Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen |
| ATE223201T1 (de) | 1996-12-18 | 2002-09-15 | Bimeda Res & Dev Ltd | Infektionsfreie intramammäre tierarzneimittelzusammenstellung |
| CA2212300A1 (en) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| CA2427938C (en) | 1999-11-15 | 2010-02-16 | Bio Syntech Canada Inc. | Novel temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution, composition and preparation thereof |
| EP1255576B1 (en) | 1999-12-09 | 2003-08-20 | Biosyntech Canada Inc. | Mineral-polymer hybrid composition |
| US20040047892A1 (en) | 2000-11-15 | 2004-03-11 | Desrosiers Eric Andre | Filler composition for soft tissue augmentation and reconstructive surgery |
| GB2394896B (en) | 2001-09-10 | 2005-06-22 | Bimeda Res & Dev Ltd | A bio-security system |
| KR100474945B1 (ko) | 2002-01-10 | 2005-03-10 | 알앤엘생명과학주식회사 | 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물 |
| RU2329064C2 (ru) * | 2003-07-31 | 2008-07-20 | Фармация Энд Апджон Компани Ллс | Диспергируемая фармацевтическая композиция для лечения мастита и поражений уха |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| MXPA06008769A (es) | 2004-02-02 | 2007-02-16 | Bimeda Res & Dev Ltd | Metodo y dispositivo para tratar un canal de tetilla de un animal. |
| US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
| BRPI0519754A2 (pt) * | 2005-01-13 | 2009-03-10 | Cinv Ag | materiais compàsitos contendo nanopartÍculas de carbono |
| CA2593043A1 (en) * | 2005-02-03 | 2006-08-10 | Cinvention Ag | Drug delivery materials made by sol/gel technology |
| US9205046B2 (en) | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Enhanced stability of inverse thermal gelling composite hydrogels |
| US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
| WO2007066837A1 (en) | 2005-12-06 | 2007-06-14 | Lg Household & Health Care Ltd. | Delivery system for tooth whitening component using in situ gelling |
| EP3381463A1 (en) | 2006-06-30 | 2018-10-03 | BioMimetic Therapeutics, LLC | Pdgf-biomatrix compositions and methods for treating rotator cuff injuries |
| NZ549249A (en) | 2006-08-18 | 2009-10-30 | Univ Massey | Methods for reducing the incidence of mastitis by administration of keratin |
| ZA200902544B (en) | 2006-10-10 | 2010-08-25 | Wisconsin Alumni Res Found | Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| EP2097065A2 (en) | 2006-11-29 | 2009-09-09 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
| US8153612B2 (en) | 2006-12-11 | 2012-04-10 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| US9034348B2 (en) | 2006-12-11 | 2015-05-19 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| AU2007331071A1 (en) * | 2006-12-11 | 2008-06-19 | Mor Research Applications Ltd. | Novel injectable chitosan mixtures forming hydrogels |
| EP2337544A2 (en) | 2007-04-30 | 2011-06-29 | Living Proof, Inc. | Use of matrix metalloproteinase inhibitors in skin care |
| CN101077377A (zh) * | 2007-05-09 | 2007-11-28 | 史义林 | 防治牛、羊乳房炎的复方碘化壳聚糖涂膜剂及其制备方法 |
| US20090081173A1 (en) | 2007-08-10 | 2009-03-26 | The Board Of Regents Of The University Of Texas System | Methods and compositions involving bacteriophage isolates |
| GB2461186B (en) * | 2008-04-21 | 2010-09-01 | Otonomy Inc | Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| US20100092526A1 (en) * | 2008-09-26 | 2010-04-15 | Nanobio Corporation | Nanoemulsion therapeutic compositions and methods of using the same |
| US20100143510A1 (en) * | 2008-12-04 | 2010-06-10 | Majid Razzak | Intramammary teat sealant |
| WO2010065908A2 (en) * | 2008-12-05 | 2010-06-10 | Catchmark Jeffrey M | Degradable biomolecule compositions |
| MY158710A (en) | 2008-12-16 | 2016-11-15 | Carlsberg As | Coating of hydroxylated surfaces by gas phase grafting |
| US20100196347A1 (en) | 2008-12-19 | 2010-08-05 | Vladimir Kery | Bone grafts with reduced protease activity and methods of selection and use |
| WO2011022070A2 (en) | 2009-08-20 | 2011-02-24 | The Regents Of The University Of California | Perivascular stem cell composition for bone |
| CN101664381A (zh) * | 2009-08-21 | 2010-03-10 | 天津生机集团股份有限公司 | 治疗奶牛乳房炎的原位凝胶缓释制剂的制备方法 |
| CN102125516B (zh) * | 2010-01-13 | 2014-03-26 | 北京大学 | 温敏型原位凝胶药物组合物 |
| EP2606121B1 (en) | 2010-08-19 | 2016-05-11 | The Regents of The University of California | Compositions comrpising perivascular stem cells and nell-1 protein |
| WO2012080494A1 (en) | 2010-12-16 | 2012-06-21 | Specialites Pet Food | Method for producing highly palatable dry cat food |
| GB201113606D0 (en) | 2011-08-05 | 2011-09-21 | Norbrook Lab Ltd | Dual chamber syringe |
| WO2013062995A1 (en) | 2011-10-25 | 2013-05-02 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating deep partial and full thickness wounds and injuries |
| US20130108670A1 (en) | 2011-10-25 | 2013-05-02 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating full thickness burn injuries |
| EP2917299A4 (en) | 2012-11-09 | 2016-06-29 | Bioastra Technologies Inc | NANOSTRUCTURED PHASE SWITCHING MATERIALS FOR SOLID WATER HEAT MANAGEMENT |
| RU2521401C1 (ru) * | 2012-12-07 | 2014-06-27 | ГНУ Краснодарский научно-исследовательский ветеринарный институт Российская академия сельскохозяйственных наук (Краснодарский НИВИ) | Средство для профилактики мастита у дойных коров в сухостойный период |
| MX360649B (es) | 2013-03-13 | 2018-11-12 | Anteis Sa | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
| US9968603B2 (en) | 2013-03-14 | 2018-05-15 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
| UA119642C2 (uk) * | 2013-03-15 | 2019-07-25 | Меріал, Інк. | Протимікробні поліамідні композиції та лікування маститу |
| SG10201710796PA (en) | 2013-03-15 | 2018-02-27 | Human Biomolecular Res Institute | Compounds and matrices for use in bone growth and repair |
| TW201532621A (zh) | 2013-04-22 | 2015-09-01 | Neocutis Sa | 抗氧化劑組成物及其使用方法 |
| CN103381139A (zh) | 2013-05-10 | 2013-11-06 | 南京农业大学 | 黄芪多糖注射用原位凝胶及其制备方法 |
| CA2923555C (en) | 2013-09-16 | 2020-06-16 | Zoetis Services Llc | Assembly for sequentially delivering substances, and associated methods |
| CN104510729A (zh) | 2013-09-26 | 2015-04-15 | 黄永 | 激活动物免疫抗性的脂肪酸及其衍生物的组合物 |
| WO2016054592A1 (en) | 2014-10-03 | 2016-04-07 | Cytori Therapeutics, Inc. | Use of regenerative cells in mitigating burn progression and improving skin graft incorporation and healing |
-
2016
- 2016-11-02 AU AU2016350868A patent/AU2016350868B2/en active Active
- 2016-11-02 EP EP16805561.4A patent/EP3370698B1/en active Active
- 2016-11-02 PT PT168055614T patent/PT3370698T/pt unknown
- 2016-11-02 PL PL16805561T patent/PL3370698T3/pl unknown
- 2016-11-02 MX MX2018005547A patent/MX2018005547A/es active IP Right Grant
- 2016-11-02 WO PCT/US2016/060015 patent/WO2017079216A1/en active Application Filing
- 2016-11-02 JP JP2018543015A patent/JP6864001B2/ja active Active
- 2016-11-02 CA CA3002214A patent/CA3002214C/en active Active
- 2016-11-02 KR KR1020187015258A patent/KR102145435B1/ko active IP Right Grant
- 2016-11-02 US US15/341,028 patent/US10064870B2/en active Active
- 2016-11-02 CN CN201680064154.4A patent/CN108601723B/zh active Active
- 2016-11-02 ES ES16805561T patent/ES2907686T3/es active Active
- 2016-11-02 BR BR112018009010-7A patent/BR112018009010B1/pt active IP Right Grant
- 2016-11-02 RU RU2018115574A patent/RU2761212C2/ru active
- 2016-11-03 UY UY0001036973A patent/UY36973A/es active IP Right Grant
-
2018
- 2018-05-03 CL CL2018001194A patent/CL2018001194A1/es unknown
- 2018-08-08 US US16/058,686 patent/US10729698B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3002214A1 (en) | 2017-05-11 |
| AU2016350868B2 (en) | 2022-03-31 |
| RU2761212C2 (ru) | 2021-12-06 |
| EP3370698A1 (en) | 2018-09-12 |
| BR112018009010B1 (pt) | 2023-09-26 |
| PT3370698T (pt) | 2022-03-02 |
| CN108601723A (zh) | 2018-09-28 |
| UY36973A (es) | 2017-06-30 |
| US20170119785A1 (en) | 2017-05-04 |
| CA3002214C (en) | 2022-01-04 |
| BR112018009010A2 (pt) | 2018-10-30 |
| CN108601723B (zh) | 2022-05-17 |
| KR20180075646A (ko) | 2018-07-04 |
| AU2016350868A1 (en) | 2018-05-10 |
| PL3370698T3 (pl) | 2022-04-25 |
| WO2017079216A1 (en) | 2017-05-11 |
| JP2018536708A (ja) | 2018-12-13 |
| JP6864001B2 (ja) | 2021-04-21 |
| EP3370698B1 (en) | 2022-01-26 |
| US10729698B2 (en) | 2020-08-04 |
| ES2907686T3 (es) | 2022-04-26 |
| US10064870B2 (en) | 2018-09-04 |
| BR112018009010A8 (pt) | 2019-02-26 |
| RU2018115574A3 (es) | 2020-03-13 |
| MX2018005547A (es) | 2018-11-09 |
| US20190030043A1 (en) | 2019-01-31 |
| KR102145435B1 (ko) | 2020-08-18 |
| RU2018115574A (ru) | 2019-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018001194A1 (es) | Compuestos polimericos sol-gel y usos de los mismos | |
| DOP2021000112A (es) | Compuestos de pirrolizina sustituida y usos de los mismos | |
| CL2016002252A1 (es) | Anticuerpos anti-egfrviii y usos de los mismos | |
| ES2966909T3 (es) | Compuestos y composiciones antimicrobianos, y usos de los mismos | |
| BR112017009204A2 (pt) | Derivados de feniltriazol hidroxialquil- substituído e usos dos mesmos | |
| CL2016000251A1 (es) | Anticuerpos anti-activina y usos de los mismos | |
| CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
| BR112016016289A2 (pt) | heteroaris e usos dos mesmos | |
| DE102016105630A8 (de) | Kappe | |
| ES2962672T8 (es) | Dispositivo de seguridad extraíble | |
| DK3313695T3 (da) | Sikkerhedsanordning | |
| CL2017002226A1 (es) | Etv2 y usos de los mismos | |
| BR112016029232A2 (pt) | estruturas que compreendem fibras poliméricas | |
| DK3163094T3 (da) | Fastgørelsesanordning | |
| DE112016002351A5 (de) | Halteelement | |
| DE112015006434A5 (de) | Filtervorrichtung | |
| DK3286392T3 (da) | Låseindretning | |
| FR3025742B1 (fr) | Element de securite | |
| ES1161084Y (es) | Dispositivo para escalada | |
| SE1651477A1 (sv) | Spärrenhet | |
| FI11467U1 (fi) | Suojaverkko | |
| ES1154583Y (es) | Conjunto de protección para ciclistas | |
| ITFI20150027U1 (it) | Assorbente ascellare | |
| UA32084S (uk) | Замикальний пристрій | |
| ES1147287Y (es) | Protector intimo de uso femenino |